DCPH - Deciphera Pharmaceuticals, Inc.
IEX Last Trade
12.94
0.120 0.927%
Share volume: 346,158
Last Updated: Tue 08 Aug 2023 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$12.82
0.12
0.94%
Summary score
23%
Profitability
22%
Dept financing
6%
Liquidity
74%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.99%
Return on assets
-11.44%
Return on sales
-280.89%
Return on invested capital
11.88%
Total debt ratio
18.89%
Debt ratio change over timeo
-0.97%
Current Ratio
7.14%
Quick Ratio
6.16%
Cash Position Ratio
4.84%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.43%
Return on assets
-10.31%
Return on sales
-137.68%
Return on invested capital
203.96%
Total debt ratio
22.14%
Debt ratio change over timeo
-1.02%
Current Ratio
4.93%
Quick Ratio
4.64%
Cash Position Ratio
4.05%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-12.99%
Return on assets
-10.78%
Return on sales
-123.95%
Return on invested capital
392.44%
Total debt ratio
23.33%
Debt ratio change over time
-0.94%
Current Ratio
4.5%
Quick Ratio
4.2%
Cash Position Ratio
3.65%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.32%
Return on assets
-101.83%
Return on sales
-132.69%
Return on invested capital
-71.74%
Total debt ratio
-97.07%
Debt ratio change over time
-0.97%
Current Ratio
0.25%
Quick Ratio
-0.55%
Cash Position Ratio
-0.53%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | DCPH | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.99% | 7.58% | 36.15% | 7.75% |
| Return on assets | -11.44% | 2.95% | 3.44% | 5.85% |
| Return on sales | -280.89% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | 11.88% | 3.7% | 6.05% | 20.44% |
| Profitability | 15% | 41% | 68% | 80% |
| Total debt ratio | 18.89% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | -0.97% | 292.67% | 15.45% | 1.02% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 4.93% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 4.64% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 4.05% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 11% | 18% | 39% |
| Short-term ratios | DCPH | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.43% | 11.57% | 35.05% | 4.21% |
| Return on assets | -10.31% | 2.86% | 2.7% | 3.6% |
| Return on sales | -137.68% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | 203.96% | 2.16% | 6.93% | 9.79% |
| Profitability | 25% | 49% | 68% | 54% |
| Total debt ratio | 22.14% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | -1.02% | 102.83% | 13.09% | 1.3% |
| Dept financing | 6% | 49% | 28% | 6% |
| Current Ratio | 4.93% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 4.64% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 4.05% | 0.3% | 1.72% | 2.75% |
| Liquididy | 73% | 11% | 35% | 66% |